Testing zavegepant nasal spray in children with migraines
Treatments studied
Part of Brain & nervous system clinical trials.
This trial tests whether the medicine zavegepant (given as a nasal spray) is safe and works well for children aged 6 to 11 who have a history of migraines. If your child gets migraines, this study may help find a new treatment option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 6 and 11 years old.
- Your child must have had migraines (with or without aura) for at least 6 months.
- Your child must weigh more than 15 kg (about 33 pounds).
- Your child cannot have a constant, unending headache that never goes away.
- Your child cannot have certain other medical conditions that might affect the study, like liver problems or abnormal heart tests.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 study checks the long-term safety of rimegepant, a migraine treatment, in children and teens. You might join if your child has had migraine for at least 6 months and still gets a certain number of moderate-to-severe migraine attacks.
This study tests a nasal spray called zavegepant to see how well it treats migraine attacks quickly. It may help people who have frequent migraines and need a fast-acting treatment.
This trial tests a nasal spray medicine called zavegepant to see if it can quickly stop cluster headache attacks. Cluster headaches are very painful headaches that happen in cycles or bouts.
This trial tests whether a new class of migraine medicines, called gepants, can relieve migraine pain quickly when given in the emergency department. If you're having a migraine and haven't taken pain medication recently, you might be able to join.
This study tests how well a new acute migraine medicine, zavegepant, works and is tolerated in people who are already taking a CGRP-targeting preventive medication. It may help you find an effective treatment when you get a migraine attack.
This trial studies a medicine for stopping a migraine attack in children and teens. It may help families understand which treatment works best during acute (during-attack) migraine pain.
Hear when a new Acute Treatment of Migraine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.